Nanobeads (column-based positive selection) · Catalogue PM019
Anti-mouse CD19 nanobeads bind CD19⁺ B cells directly and are retained on a column in a magnetic field. In mouse spleen the manual reports 55.6% CD19⁺ before separation and 94.4% after a single positive selection, with 1.54% residual CD19⁺ cells in the flow-through. CD19 is expressed from pro-B to mature B cells and on follicular dendritic cells; plasma cells are negative.
| Catalogue | Size | List price | Promo price | Manual | COA |
|---|---|---|---|---|---|
| PM019L | 2 mL, for 2e+9 cells | ¥4000 | ¥3200 | Search | |
| PM019M | 1 mL, for 1e+9 cells | ¥2500 | ¥2000 | Search | |
| PM019S | 0.2 mL, for 2e+8 cells | ¥700 | ¥560 | Search |
Mouse spleen was labelled with anti-mouse CD19 Nanobeads at 10 μL per 1×107 cells, incubated at 4 °C for 10 min and separated on a column. The eluted positive fraction and the flow-through were stained with APC anti-mouse CD19 and analysed by flow cytometry.
| Readout | Result |
|---|---|
| CD19⁺ before separation (mouse spleen) | 55.6% |
| CD19⁺ purity after one positive selection (positive fraction) | 94.4% |
| CD19⁺ carry-over in the flow-through (depleted fraction) | 1.54% |
94.4% refers to CD19⁺ cell purity — predominantly B cells, with a possible minor FDC component; plasma cells are CD19-negative and outside the selected fraction. Data come from a single sample and a single separation without absolute cell counts, so they are not converted to yield. Tissues with a lower starting frequency, such as bone marrow, give lower purity on a single column.
CD19 is expressed from pro-B through mature B cells and on follicular dendritic cells (FDCs); plasma cells are negative. The selected fraction is therefore a CD19⁺ population that is predominantly B cells but may contain a small number of FDCs. To resolve transitional, follicular or marginal-zone subsets, add CD23, CD43, IgD or IgM to the panel.
No. Plasma cells downregulate CD19 after terminal differentiation, so they fall outside the CD19⁺ gate. If antibody-secreting cells are the target, use a plasma-cell marker such as CD138 or run ELISPOT on the immunised tissue directly.
Mince the spleen, filter through a 70 μm sterile nylon mesh, lyse red blood cells and count (AO/PI staining recommended). CD19⁺ cells typically account for 10–60% of mouse spleen (55.6% in the manual validation sample); one spleen yields roughly 0.5–1×10⁸ cells.
At 1×10⁸ cells/mL, dose by CD19⁺ frequency: 1–5 μL per 1×10⁷ cells for tissue samples below 10%, and 10 μL per 1×10⁷ cells for mouse spleen at 10–60%. Keep labelling at 4 °C for 10 min; do not increase the amount to chase purity, as excess bead raises non-specific binding.
M column: <1×10⁷ labelled cells / <2×10⁸ total cells, with magnet M1/M8, 500 μL equilibration and 3×500 μL washes. L column: <1×10⁸ labelled cells / <2×10⁹ total cells, with magnet L1/L4, 3 mL equilibration and 3×3 mL washes. One mouse spleen (0.5–1×10⁸ cells) normally fits an M column; size by total cell count, not by the post-filter estimate.
Yes. The flow-through from loading and washing is the CD19-depleted fraction; the manual reports 1.54% residual CD19⁺ cells. This suits non-B-cell enrichment or control arms in B-cell-dependent functional assays, with no second reagent required.
Yes, but judge whether it is worth it. When CD19⁺ frequency is low (bone marrow, blood), repeat the equilibrate–load–wash–elute cycle on a fresh column to gain purity. At normal spleen frequency (55.6%) a second pass mainly costs cells and is usually unnecessary.
PBS lacks protein protection and osmotic buffering, which lowers recovery and viability. Use FACS buffer (1× PBS with 0.02% EDTA and 2% FBS) or Eynos separation buffer; buffer quality often matters more than the bead itself.
Yes. At 94.4% purity the target cells are far more concentrated per unit volume than in the starting sample, so add antibody according to total cell number rather than reusing the pre-sort volume; otherwise under-staining will distort intensity and gating.
Not directly. The 94.4% figure comes from mouse spleen (55.6% starting). CD19⁺ frequency in bone marrow is much lower, so a single column gives lower purity and a second pass is usually needed. Starting frequency and subset composition differ between tissues and mouse strains, so each source should be benchmarked.
Bubbles usually come from protein-containing buffer. Fill the column with 3 mL of FACS buffer before pushing the cells out, and press the plunger once — do not pump repeatedly. If bubbles persist, switch to a high-quality PBS for the elution step.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.